Histone modifications are associated with 9-tetrahydrocannabinol-mediated alterations in antigenspecific t cell responses

Journal of Biological Chemistry

Volumn 289, Issue 27, 2014, Pages 18707-18718

  Yang, Xiaoming ^a   Hegde, Venkatesh L ^a   Rao, Roshni ^a   Zhang, Jiajia ^b   Nagarkatti, Prakash S ^a   Nagarkatti, Mitzi ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATION;

HISTONE METHYLATION; HISTONE MODIFICATION; IMMUNE CELLS; IMMUNOMODULATORY ACTIVITIES; T-CELL RESPONSE;

ANTIGENS;

DRONABINOL; HISTONE H3; LYSINE; STAPHYLOCOCCUS ENTEROTOXIN B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IN VIVO STUDY; LYMPH NODE CELL; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EPIGENETICS; HISTONE METHYLATION; IMMUNOSUPPRESSION; LYMPHOCYTE; T-CELL;

ANIMALS; CELL PROLIFERATION; DRONABINOL; ENTEROTOXINS; FEMALE; GENETIC MARKERS; GENOMICS; HISTONES; IMMUNOLOGIC FACTORS; LYMPH NODES; METHYLATION; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTOME;

EID: 84903837980     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.545210     Document Type: Article

References (77)

1. Substance Abuse and Mental Health Services Administration (2010) Results from the 2009 National Survey on Drug Use and Heath: Summary of National Findings, United States Department of Health and Human Services, Washington, D. C.
2. Todaro, B. (2012) Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting. J. Natl. Compr. Canc. Netw. 10, 487-492
3. Cinti, S. (2009) Medical marijuana in HIV-positive patients: what do we know? J. Int. Assoc. Physicians AIDS Care. Chic. 8, 342-346.
4. Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232, 54-61
5. Bouaboula, M., Rinaldi, M., Carayon, P., Carillon, C., Delpech, B., Shire, D., Le Fur, G., and Casellas, P. (1993) Cannabinoid-receptor expression in human leukocytes. Eur. J. Biochem. 214, 173-180
6. Do, Y., McKallip, R. J., Nagarkatti, M., and Nagarkatti, P. S. (2004) Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-B-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation. J. Immunol. 173, 2373-2382
7. Rao, G. K., Zhang, W., and Kaminski, N. E. (2004) Cannabinoid receptormediated regulation of intracellular calcium by -9-tetrahydrocannabinol in resting T cells. J. Leukoc. Biol. 75, 884-892
8. Newton, C. A., Klein, T. W., and Friedman, H. (1994) Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by -9-tetrahydrocannabinol injection. Infect. Immun. 62, 4015-4020
9. Klein, T. W., Newton, C. A., Nakachi, N., and Friedman, H. (2000) -9- Tetrahydrocannabinol treatment suppresses immunity and early IFN-, IL-12, and IL-12 receptor -2 responses to Legionella pneumophila infection. J. Immunol. 164, 6461-6466
10. Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., and Roth, M. D. (2002) -9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133, 124-131
11. Hegde, V. L., Nagarkatti, M., and Nagarkatti, P. S. (2010) Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. Eur. J. Immunol. 40, 3358-3371
12. Kusmartsev, S. A., Li, Y., and Chen, S. H. (2000) Gr-1- myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165, 779-785
13. Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., and Zanovello, P. (2000) Identification of a CD11b-/Gr-1-/ CD31- myeloid progenitor capable of activating or suppressing CD8- T cells. Blood 96, 3838-3846
14. Hegde, V. L., Hegde, S., Cravatt, B. F., Hofseth, L. J., Nagarkatti, M., and Nagarkatti, P. S. (2008) Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol. Pharmacol. 74, 20-33
15. Hegde, V. L., Tomar, S., Jackson, A., Rao, R., Yang, X., Singh, U. P., Singh, N. P., Nagarkatti, P. S., and Nagarkatti, M. (2013) Distinct microRNA expression profile and targeted biological pathways in functional myeloidderived suppressor cells induced by -9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer binding protein - by microRNA-690. J. Biol. Chem. 288, 36810-36826
16. Lombard, C., Hegde, V. L., Nagarkatti, M., and Nagarkatti, P. S. (2011) Perinatal exposure to -9-tetrahydrocannabinol triggers profound defects in T cell differentiation and function in fetal and postnatal stages of life, including decreased responsiveness to HIV antigens. J. Pharmacol. Exp. Ther. 339, 607-617
17. Araki, Y., Wang, Z., Zang, C., Wood, W. H., 3rd, Schones, D., Cui, K., Roh, T. Y., Lhotsky, B., Wersto, R. P., Peng, W., Becker, K. G., Zhao, K., and Weng, N. P. (2009) Genome-wide analysis of histone methylation reveals chromatin state-based regulation of gene transcription and function of memory CD8- T cells. Immunity 30, 912-925
18. Morinobu, A., Kanno, Y., and O'Shea, J. J. (2004) Discrete roles for histone acetylation in human T helper 1 cell-specific gene expression. J. Biol. Chem. 279, 40640-40646
19. Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., and Zhao, K. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129, 823-837
20. Roh, T. Y., Cuddapah, S., Cui, K., and Zhao, K. (2006) The genomic landscape of histone modifications in human T cells. Proc. Natl. Acad. Sci. U. S. A. 103, 15782-15787
21. Lim, P. S., Hardy, K., Bunting, K. L., Ma, L., Peng, K., Chen, X., and Shannon, M. F. (2009) Defining the chromatin signature of inducible genes in T cells. Genome Biol. 10, R107
22. Greer, E. L., and Shi, Y. (2012) Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13, 343-357
23. Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R., Schreiber, S. L., and Lander, E. S. (2006)Abivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326
24. Roh, T. Y., Wei, G., Farrell, C. M., and Zhao, K. (2007) Genome-wide prediction of conserved and nonconserved enhancers by histone acetylation patterns. Genome Res. 17, 74-81
25. Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., Cui, K., Kanno, Y., Roh, T. Y., Watford, W. T., Schones, D. E., Peng, W., Sun, H. W., Paul, W. E., O'Shea, J. J., and Zhao, K. (2009) Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4- T cells. Immunity 30, 155-167
26. Bannister, A. J., Schneider, R., Myers, F. A., Thorne, A. W., Crane-Robinson, C., and Kouzarides, T. (2005) Spatial distribution of di- and trimethyl lysine 36 of histone H3 at active genes. J. Biol. Chem. 280, 17732-17736
27. Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T. K., Koche, R. P., Lee, W., Mendenhall, E., O'Donovan, A., Presser, A., Russ, C., Xie, X., Meissner, A., Wernig, M., Jaenisch, R., Nusbaum, C., Lander, E. S., and Bernstein, B. E. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560
28. Vakoc, C. R., Mandat, S. A., Olenchock, B. A., and Blobel, G. A. (2005) Histone H3 lysine 9 methylation and HP1- are associated with transcription elongation through mammalian chromatin. Mol. Cell 19, 381-391
29. Wang, Z., Zang, C., Rosenfeld, J. A., Schones, D. E., Barski, A., Cuddapah, S., Cui, K., Roh, T. Y., Peng, W., Zhang, M. Q., and Zhao, K. (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat. Genet. 40, 897-903
30. Squazzo, S. L., O'Geen, H., Komashko, V. M., Krig, S. R., Jin, V. X., Jang, S. W., Margueron, R., Reinberg, D., Green, R., and Farnham, P. J. (2006) Suz12 binds to silenced regions of the genome in a cell-type-specific manner. Genome Res. 16, 890-900
31. Karmodiya, K., Krebs, A. R., Oulad-Abdelghani, M., Kimura, H., and Tora, L. (2012) H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genomics 13, 424
32. Fraser, J. D., and Proft, T. (2008) The bacterial superantigen and superantigen- like proteins. Immunol. Rev. 225, 226-243
33. Pandey, R., Hegde, V. L., Nagarkatti, M., and Nagarkatti, P. S. (2011) Targeting cannabinoid receptors as a novel approach in the treatment of graft- versus -host disease: evidence from an experimental murine model. J. Pharmacol. Exp. Ther. 338, 819-828
34. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25
35. Zang, C., Schones, D. E., Zeng, C., Cui, K., Zhao, K., and Peng, W. (2009) A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 25, 1952-1958
36. Blankenberg, D., Von Kuster, G., Coraor, N., Ananda, G., Lazarus, R., Mangan, M., Nekrutenko, A., and Taylor, J. (2010) Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol., Chapter 19, Unit 19. 10, 11-21
37. Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., Ali, S., Chin, S. F., Palmieri, C., Caldas, C., and Carroll, J. S. (2012) Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature 481, 389-393
38. Shin, H., Liu, T., Manrai, A. K., and Liu, X. S. (2009) CEAS: cis-regulatory element annotation system. Bioinformatics 25, 2605-2606
39. Liu, T., Ortiz, J. A., Taing, L., Meyer, C. A., Lee, B., Zhang, Y., Shin, H., Wong, S. S., Ma, J., Lei, Y., Pape, U. J., Poidinger, M., Chen, Y., Yeung, K., Brown, M., Turpaz, Y., and Liu, X. S. (2011) Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 12, R83
40. Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., and Nagarkatti, M. (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med. Chem. 1, 1333-1349
41. Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P., and Dubinett, S. M. (2000) -9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165, 373-380
42. Shahbazian, M. D., and Grunstein, M. (2007) Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76, 75-100
43. Klose, R. J., and Zhang, Y. (2007) Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8, 307-318
44. Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., Bell, G. W., Otte, A. P., Vidal, M., Gifford, D. K., Young, R. A., and Jaenisch, R. (2006) Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441, 349-353
45. Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K., Koseki, H., Fuchikami, T., Abe, K., Murray, H. L., Zucker, J. P., Yuan, B., Bell, G. W., Herbolsheimer, E., Hannett, N. M., Sun, K., Odom, D. T., Otte, A. P., Volkert, T. L., Bartel, D. P., Melton, D. A., Gifford, D. K., Jaenisch, R., and Young, R. A. (2006) Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125, 301-313
46. Vastenhouw, N. L., and Schier, A. F. (2012) Bivalent histone modifications in early embryogenesis. Curr. Opin. Cell Biol. 24, 374-386
47. Karmaus, P. W., Chen, W., Crawford, R., Kaplan, B. L., and Kaminski, N. E. (2013) -9-Tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2. Toxicol. Sci. 131, 419-433
48. Zhu, W., Friedman, H., and Klein, T. W. (1998) -9-Tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1. J. Pharmacol. Exp. Ther. 286, 1103-1109
49. Kozela, E., Juknat, A., Kaushansky, N., Rimmerman, N., Ben-Nun, A., and Vogel, Z. (2013) Cannabinoids decrease the th17 inflammatory autoimmune phenotype. J. Neuroimmune Pharmacol. 8, 1265-1276
50. Mercer, T. R., and Mattick, J. S. (2013) Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 20, 300-307
51. Tam, W. (2001) Identification and characterization of human BIC, a geneon chromosome 21 that encodes a noncoding RNA. Gene 274, 157-167
52. Haasch, D., Chen, Y. W., Reilly, R. M., Chiou, X. G., Koterski, S., Smith, M. L., Kroeger, P., McWeeny, K., Halbert, D. N., Mollison, K. W., Djuric, S. W., and Trevillyan, J. M. (2002) T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC. Cell Immunol. 217, 78-86
53. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., van Dongen, S., Grocock, R. J., Das, P. P., Miska, E. A., Vetrie, D., Okkenhaug, K., Enright, A. J., Dougan, G., Turner, M., and Bradley, A. (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611
54. Terlou, A., Santegoets, L. A., van der Meijden, W. I., Heijmans-Antonissen, C., Swagemakers, S. M., van der Spek, P. J., Ewing, P. C., van Beurden, M., Helmerhorst, T. J., and Blok, L. J. (2012) An autoimmune phenotype in vulvar lichen sclerosus and lichen planus: a Th1 response and high levels of microRNA-155. J. Invest. Dermatol. 132, 658-666
55. O'Connell, R. M., Kahn, D., Gibson, W. S., Round, J. L., Scholz, R. L., Chaudhuri, A. A., Kahn, M. E., Rao, D. S., and Baltimore, D. (2010) MicroRNA- 155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33, 607-619
56. Incoronato, M., Garofalo, M., Urso, L., Romano, G., Quintavalle, C., Zanca, C., Iaboni, M., Nuovo, G., Croce, C. M., and Condorelli, G. (2010) miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED. Cancer Res. 70, 3638-3646
57. Lagos, D., Pollara, G., Henderson, S., Gratrix, F., Fabani, M., Milne, R. S., Gotch, F., and Boshoff, C. (2010) miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat. Cell Biol. 12, 513-519
58. Shaked, I., Meerson, A., Wolf, Y., Avni, R., Greenberg, D., Gilboa-Geffen, A., and Soreq, H. (2009) MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 31, 965-973
59. Remenyi, J., van den Bosch, M. W., Palygin, O., Mistry, R. B., McKenzie, C., Macdonald, A., Hutvagner, G., Arthur, J. S., Frenguelli, B. G., and Pankratov, Y. (2013) miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity. PLoS One 8, e62509
60. Paradisi, A., Pasquariello, N., Barcaroli, D., and Maccarrone, M. (2008) Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner. J. Biol. Chem. 283, 6005-6012
61. Aguado, T., Carracedo, A., Julien, B., Velasco, G., Milman, G., Mechoulam, R., Alvarez, L., Guzmán, M., and Galve-Roperh, I. (2007) Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J. Biol. Chem. 282, 6854-6862
62. Sadri-Vakili, G., Bouzou, B., Benn, C. L., Kim, M. O., Chawla, P., Overland, R. P., Glajch, K. E., Xia, E., Qiu, Z., Hersch, S. M., Clark, T. W., Yohrling, G. J., and Cha, J. H. (2007) Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models. Hum. Mol. Genet. 16, 1293-1306
63. Khare, M., Taylor, A. H., Konje, J. C., and Bell, S. C. (2006) -9-Tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol. Hum. Reprod. 12, 321-333
64. Guenther, M. G., and Lazar, M. A. (2003) Biochemical isolation and analysis of a nuclear receptor corepressor complex. Methods Enzymol. 364, 246-257
65. Chioccarelli, T., Cacciola, G., Altucci, L., Lewis, S. E., Simon, L., Ricci, G., Ledent, C., Meccariello, R., Fasano, S., Pierantoni, R., and Cobellis, G. (2010) Cannabinoid receptor 1 influences chromatin remodeling in mouse spermatids by affecting content of transition protein 2 mRNA and histone displacement. Endocrinology 151, 5017-5029
66. Ellert-Miklaszewska, A., Kaminska, B., and Konarska, L. (2005) Cannabinoids down-regulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein. Cell. Signal. 17, 25-37
67. Greenhough, A., Patsos, H. A., Williams, A. C., and Paraskeva, C. (2007) The cannabinoid -9-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int. J. Cancer 121, 2172-2180
68. Zuo, T., Liu, T. M., Lan, X., Weng, Y. I., Shen, R., Gu, F., Huang, Y. W., Liyanarachchi, S., Deatherage, D. E., Hsu, P. Y., Taslim, C., Ramaswamy, B., Shapiro, C. L., Lin, H. J., Cheng, A. S., Jin, V. X., and Huang, T. H. (2011) Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer. Cancer Res. 71, 1752-1762
69. Ozaita, A., Puighermanal, E., and Maldonado, R. (2007) Regulation of PI3K/Akt/GSK-3 pathway by cannabinoids in the brain. J. Neurochem. 102, 1105-1114
70. Cha, T. L., Zhou, B. P., Xia, W., Wu, Y., Yang, C. C., Chen, C. T., Ping, B., Otte, A. P., and Hung, M. C. (2005) Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310, 306-310
71. Liu, Y., Xing, Z. B., Zhang, J. H., and Fang, Y. (2013) Akt kinase targets the association of CBP with histone H3 to regulate the acetylation of lysine K18. FEBS Lett. 587, 847-853
72. Garcia-Bassets, I., Kwon, Y. S., Telese, F., Prefontaine, G. G., Hutt, K. R., Cheng, C. S., Ju, B. G., Ohgi, K. A., Wang, J., Escoubet-Lozach, L., Rose, D. W., Glass, C. K., Fu, X. D., and Rosenfeld, M. G. (2007) Histone methylation- dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128, 505-518
73. Kawazu, M., Saso, K., Tong, K. I., McQuire, T., Goto, K., Son, D. O., Wakeham, A., Miyagishi, M., Mak, T. W., and Okada, H. (2011) Histone demethylase JMJD2B functions as a co-factor of estrogen receptor in breast cancer proliferation and mammary gland development. PLoS One 6, e17830
74. Sauer, M. A., Rifka, S. M., Hawks, R. L., Cutler, G. B., Jr., and Loriaux, D. L. (1983) Marijuana: interaction with the estrogen receptor. J. Pharmacol. Exp. Ther. 224, 404-407
75. von Bueren, A. O., Schlumpf, M., and Lichtensteiger, W. (2008) -9-Tetrahydrocannabinol inhibits 17-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cells. Anticancer Res. 28, 85-89
76. Kumar, P., and Song, Z. H. (2014) CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene. Biochem. Biophys. Res. Commun. 443, 144-149
77. Prather, P. L., FrancisDevaraj, F., Dates, C. R., Greer, A. K., Bratton, S. M., Ford, B. M., Franks, L. N., and Radominska-Pandya, A. (2013) CB1 and CB2 receptors are novel molecular targets for tamoxifen and 4OH-tamoxifen. Biochem. Biophys. Res. Commun. 441, 339-343